Karyopharm appoints new CFO to bolster financial strategy By Investing.com
NEWTON, Mass. – Karyopharm Therapeutics Inc. (NASDAQ:), a company focused on the development of novel cancer therapies, announced the appointment of Lori Macomber as Executive Vice President, Chief Financial Officer, and Treasurer, effective January 3, 2025. Macomber’s role will encompass leading the financial operations of the company, including the strategic management of its finances.
Macomber brings over two decades of financial leadership experience within the life sciences sector, having previously served as CFO at Legend Biotech Corporation, a $6 billion market cap company that achieved 123% revenue growth in the last twelve months. During her tenure, Legend maintained a strong balance sheet with a current ratio of nearly 5x. Her…
